Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Interferon β from hair cells stops the growth of other hair cells.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Elagolix did not effectively treat polycystic ovary syndrome.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Hydrogel microneedles with special nanoparticles and growth factor improve hair growth better than minoxidil for hair loss treatment.

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

Finasteride increases P-glycoprotein activity in the liver and kidney.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A new patch can deliver stable antibodies over time for potential HIV treatment.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

Baricitinib shows promise in treating severe hair loss.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The FDA approved a new Pfizer drug for hair loss in teens.